76 results
CORRESP
SLNO
Soleno Therapeutics Inc
10 Apr 19
Correspondence with SEC
12:00am
authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure
CORRESP
SLNO
Soleno Therapeutics Inc
5 Feb 21
Correspondence with SEC
12:00am
or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility
S-1/A
SLNO
Soleno Therapeutics Inc
1 Jul 14
IPO registration (amended)
12:00am
not disclaim responsibility for your disclosures and a party who provides a consent for a summary that is included in the prospectus also may not disclaim … responsibility for the content of that summary. Accordingly, please tell us the purpose of the disclosure you have included in the third paragraph under
CORRESP
SLNO
Soleno Therapeutics Inc
21 Oct 14
Correspondence with SEC
12:00am
effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement
8-K/A
EX-99.1
SLNO
Soleno Therapeutics Inc
10 Apr 17
Other Events
12:00am
Responsibility for the Financial Statements
Management is responsible for the preparation and fair presentation of these financial statements in accordance … .
Auditor’s Responsibility
Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits
CORRESP
h54svw7glyn nzpm6kwd
10 Nov 14
Correspondence with SEC
12:00am
CORRESP
62kqi rl5txyp66a5tu
27 Oct 23
Correspondence with SEC
12:00am
CORRESP
gswr4nr
14 Oct 14
Correspondence with SEC
12:00am
CORRESP
7v8k 7wfba
8 Aug 14
Correspondence with SEC
12:00am
CORRESP
jbibv
22 Jul 19
Correspondence with SEC
12:00am
CORRESP
wsneo
17 Oct 14
Correspondence with SEC
12:00am
8-K
0okdfu57w36xil5
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-1.2
vz98vk7bnp 1x
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm